Abstract 60: Semaphorin 7a promotes cell survival and resistance to endocrine therapy in ER+ breast cancer

Authors: Traci Renae Lyons

Published: 2020-09-04

DOI: 10.1158/1538-7445.am2020-60

Source: Full article


Abstract

Abstract